Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Net Current Assets

    Back to Balance Sheet
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Net Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Current Assets (Including Current Investments) ₹3,328 Cr₹1,609 Cr₹3,877 Cr₹3,593 Cr₹3,159 Cr

What is the latest Net Current Assets ratio of GLENMARK PHARMACEUTICALS ?

The latest Net Current Assets ratio of GLENMARK PHARMACEUTICALS is ₹3,328 Cr based on Mar2025 Consolidated results.
Year Net Current Assets
Mar2025₹3,328 Cr
Mar2024₹1,609 Cr
Mar2023₹3,877 Cr
Mar2022₹3,593 Cr
Mar2021₹3,159 Cr

How is Net Current Assets of GLENMARK PHARMACEUTICALS Trending?

Years Net Current Assets % Change
Mar2025 ₹3,328 Cr
106.80
Mar2024 ₹1,609 Cr
-58.49
Mar2023 ₹3,877 Cr
7.92
Mar2022 ₹3,593 Cr
13.75
Mar2021 ₹3,159 Cr -

Compare Net Current Assets of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹56,845.0 Cr -3% 3.8% 26.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,451.0 Cr 2.1% 0.3% -9.6% Stock Analytics
DIVIS LABORATORIES ₹161,727.0 Cr -0% 1.1% 13.4% Stock Analytics
CIPLA ₹124,533.0 Cr -1.1% -3.2% -4.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹123,673.0 Cr 3.4% 0.2% 8.1% Stock Analytics
DR REDDYS LABORATORIES ₹108,629.0 Cr -0.7% 2% 0.7% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-3%

3.8%

26.7%

SENSEX

0.5%

0.4%

-1.1%


You may also like the below Video Courses